Collegium Pharmaceutical Inc (COLL)

Debt-to-capital ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	1,663,590	234,279	216,583	222,169	195,431	178,873	200,805	179,733	194,842	197,194	197,612	196,076	202,928	251,094	253,066	170,035	186,031	172,686	155,767	141,063
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,663,590K)
= 0.00

Collegium Pharmaceutical Inc has consistently maintained a debt-to-capital ratio of 0.00, as per the financial data provided from March 31, 2020, to December 31, 2024. The debt-to-capital ratio indicates the proportion of a company's capital structure that is financed through debt. In this case, a ratio of 0.00 signifies that the company has not utilized debt to fund its operations or investments during the specified period.

A debt-to-capital ratio of 0.00 suggests that Collegium Pharmaceutical Inc is not heavily reliant on debt financing and likely relies more on equity funding or internal resources to support its business activities. This can be viewed positively by investors and creditors as it indicates lower financial risk and potential for financial stability. Furthermore, a zero debt-to-capital ratio may reflect strong liquidity, cash reserves, or a conservative financial strategy by the company.

Overall, maintaining a consistent debt-to-capital ratio of 0.00 over an extended period can be seen as a sign of financial prudence and effective capital management by Collegium Pharmaceutical Inc.